Latest Security News

Auris Minerals has raised $3.2 million through a strategic placement to expand its geological team and fast-track exploration in the Bryah Basin, focusing on copper, gold, and rare earths.

G50 Corp’s latest quarterly report reveals a significant new precious metals discovery at its Golconda Project alongside promising antimony results at White Caps, supported by a $10 million capital raise to advance exploration.

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.

Carnaby Resources has completed the acquisition of the remaining 17.5% stake in the Greater Duchess Copper Gold Joint Venture, gaining 100% ownership and full operational control. This strategic move positions Carnaby to accelerate development and unlock the project’s significant copper-gold potential.

Latitude 66 has completed the sale of its 17.5% stake in the Greater Duchess Joint Venture to Carnaby Resources for A$6 million, eliminating debt and boosting funds for exploration.

Jade Gas Holdings has raised A$5 million through a placement to advance commercial gas production at its Red Lake field, with a follow-up Share Purchase Plan aiming to raise an additional A$2.1 million.

EV Resources has appointed Michael Brown as Managing Director and CEO to spearhead its North American antimony supply strategy, aiming to restart production in Mexico and expand U.S. projects amid rising demand for critical minerals.

Clarity Pharmaceuticals has inked a pivotal supply agreement with Nusano to ensure a steady source of copper-67, a critical isotope for its upcoming Phase III prostate cancer trial and future commercialisation plans.

TrivarX Limited has resumed trading on the ASX following the announcement of a significant acquisition and a fresh capital raising, signaling a pivotal moment for the biotech company.

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.

Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.

Genesis Minerals delivered a record 72,878 ounces of gold in the September quarter, surpassing guidance and generating a robust A$166 million cash build. The company’s ASPIRE 400 growth strategy advances with key approvals and exploration success, setting the stage for sustained expansion.